XML 30 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investment in Subsidiaries - Additional Information (Detail) (USD $)
9 Months Ended 12 Months Ended 12 Months Ended
Jun. 30, 2013
Sep. 30, 2011
Jan. 31, 2011
Preferred Stock B and C
Jun. 30, 2013
Calando Pharmaceuticals, Inc.
Jan. 31, 2011
Calando Pharmaceuticals, Inc.
Sep. 30, 2011
Ablaris Therapeutics, Inc.
Jun. 30, 2013
Ablaris Therapeutics, Inc.
Jun. 30, 2013
Leonardo Biosystems, Inc.
Schedule Of Investments [Line Items]                
Ownership percentage in subsidiary 100.00%              
Investment in preferred stock     $ 9,100,000     $ 1,300,000    
Cash investment in subsidiary         1,000,000      
Investment in subsidiary through conversion of intercompany debt         8,100,000      
Amount owed by subsidiary       3,900,000     1,300,000 858,000
Stated percentage of notes and advances       8.00%        
Percentage of outstanding shares       79.00%     64.00% 3.00%
Percentage of investment ownership       76.00%     64.00%  
Aggregate purchase price of preferred shares   1,618,509       2,900,000    
Investment in preferred stock by outsider           $ 1,600,000